|
|
News for Healthier Living
Roswell Park-Led Clinical Trial Paves Way for FDA Approval of Targeted Drug for Aggressive Leukemia
The U.S. Food and Drug Administration has approved a new drug to treat an aggressive form of leukemia, based on the results of a clinical trial co-led by Eunice Wang, MD, Chief of Leukemia at Roswell Park Comprehensive Cancer Center.
December 2, 2025
December 2 2025December 1 2025November 30 2025November 29 2025November 28 2025November 27 2025November 26 2025November 25 2025November 24 2025November 23 2025November 22 2025November 21 2025November 20 2025November 19 2025
|
|
|
|
|